The triple blend enhances mental stamina, reduces brain fog, and provides sustained cognitive energy without the crash associated with stimulants
5 , 6 In contrast, some agents, such as SGLT2 inhibitors and GLP-1 receptor agonists, may be advantageous with respect to improved renal outcomes with SGLT2 inhibitors as well as improved cardiovascular (CV) outcomes with both of these classes of medications, which is a particular concern as CV effects are common and a leading cause of death among those with diabetes
Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C
Patients should avoid discontinuing Wegovy without discussing with a healthcare professional, unless experiencing severe adverse effects